Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease

被引：0

作者：

Jiansong Fang

Pengyue Zhang

Quan Wang

Chien-Wei Chiang

Yadi Zhou

Yuan Hou

Jielin Xu

Rui Chen

Bin Zhang

Stephen J. Lewis

James B. Leverenz

Andrew A. Pieper

Bingshan Li

Lang Li

Jeffrey Cummings

Feixiong Cheng

机构：

[1] Genomic Medicine Institute,Department of Biostatistics and Health Data Science, School of Medicine

[2] Lerner Research Institute,Department of Molecular Physiology and Biophysics

[3] Cleveland Clinic,Vanderbilt Genetics Institute

[4] Indiana University,Department of Biomedical Informatics, College of Medicine

[5] Vanderbilt University,Department of Pediatrics

[6] Vanderbilt University Medical Center,Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine

[7] Ohio State University,Harrington Discovery Institute

[8] Case Western Reserve University,Department of Psychiatry

[9] Case Western Reserve University,Institute for Transformative Molecular Medicine, School of Medicine

[10] Lou Ruvo Center for Brain Health,Department of Neuroscience

[11] Neurological Institute,Chambers

[12] Cleveland Clinic,Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences

[13] University Hospitals Cleveland Medical Center,undefined

[14] Case Western Reserve University,undefined

[15] Geriatric Psychiatry,undefined

[16] GRECC,undefined

[17] Louis Stokes Cleveland VA Medical Center,undefined

[18] Case Western Reserve University,undefined

[19] Case Western Reserve University,undefined

[20] School of Medicine,undefined

[21] University of Nevada Las Vegas,undefined

[22] Case Comprehensive Cancer Center,undefined

来源：

Alzheimer's Research & Therapy | / 14卷

关键词：

Alzheimer’s disease; Drug repurposing; Genome-wide association studies (GWAS); Multi-omics; Network medicine; Pioglitazone;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Alzheimer's Disease: Targets For Drug Development
Larner, A. J.
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (01) : 3 - 11
[22] Peptides as drug targets for Alzheimer's disease
Gozes, I
Spier, AD
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 344 - 344
[23] Drug repositioning and repurposing for Alzheimer disease
Clive Ballard
Dag Aarsland
Jeffrey Cummings
John O’Brien
Roger Mills
Jose Luis Molinuevo
Tormod Fladby
Gareth Williams
Pat Doherty
Anne Corbett
Janet Sultana
Nature Reviews Neurology, 2020, 16 : 661 - 673
[24] Drug repositioning and repurposing for Alzheimer disease
Ballard, Clive
Aarsland, Dag
Cummings, Jeffrey
O'Brien, John
Mills, Roger
Molinuevo, Jose Luis
Fladby, Tormod
Williams, Gareth
Doherty, Pat
Corbett, Anne
Sultana, Janet
NATURE REVIEWS NEUROLOGY, 2020, 16 (12) : 661 - 673
[25] Drug discovery and development: the role of artificial intelligence in drug repurposing
Aljofan, Mohamad
Gaipov, Abduzhappar
FUTURE MEDICINAL CHEMISTRY, 2024, 16 (07)
[26] Drug and Protein Interaction Network Construction for Drug Repurposing in Alzheimer's Disease
Dimitrakopoulos, Georgios N.
Vrahatis, Aristidis G.
Exarchos, Themis P.
Krokidis, Marios G.
Vlamos, Panagiotis
FUTURE PHARMACOLOGY, 2023, 3 (04): : 731 - 741
[27] Tamibarotene: A Candidate Retinoid Drug for Alzheimer's Disease
Fukasawa, Hiroshi
Nakagomi, Madoka
Yamagata, Naoko
Katsuki, Hiroshi
Kawahara, Kohichi
Kitaoka, Kazuyoshi
Miki, Takami
Shudo, Koichi
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (08) : 1206 - 1212
[28] Improved Candidate Drug Mining for Alzheimer's Disease
Cheng, Yu-Huei
Chuang, Li-Yeh
Chang, Hsueh-Wei
Yang, Cheng-Hong
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[29] Artificial intelligence, machine learning, and drug repurposing in cancer
Tanoli, Ziaurrehman
Vaha-Koskela, Markus
Aittokallio, Tero
EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (09) : 977 - 989
[30] Drug Repurposing and Artificial Intelligence: From Liaison to Marriage
Mucke, Hermann A. M.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2018, 16 (05) : 231 - 231

← 1 2 3 4 5 →